The New Science of Sharing
Earlier this month, Swiss drugmaker Novartis did something rather unusual—and almost unheard of in the high-stakes, highly competitive world of Big Pharma. After investing millions trying to unlock the genetic basis of type 2 diabetes, the company released all of its raw data on the Internet. This means anyone (or any company) with the inclination is free to use the data—no strings attached.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.